Last updated at 07 Jul 2024 09:08 AM
Director
DIN: 06849283
Rohit Ashok Tiwari is currently associated with 2 companies in various capacities such as Managing Director and Director. They serve as a Director at KREGAR PHARMA PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 06849283.Rohit Ashok Tiwari has previously been associated with 1 company in roles such as Director.Rohit Ashok Tiwari is currently involved in 2 different roles. Their most recent position is with BASK-RAY INDIA PRIVATE LIMITED as a Director. The first company Rohit Ashok Tiwari was appointed to as a director was KREGAR PHARMA PRIVATE LIMITED. Rohit Ashok Tiwari is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Rohit Ashok Tiwari is currently associated with 2 companies in various capacities such as Managing Director and Director. They serve as a Director at KREGAR PHARMA PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 06849283.Rohit Ashok Tiwari has previously been associated with 1 company in roles such as Director.Rohit Ashok Tiwari is currently involved in 2 different roles. Their most recent position is with BASK-RAY INDIA PRIVATE LIMITED as a Director. The first company Rohit Ashok Tiwari was appointed to as a director was KREGAR PHARMA PRIVATE LIMITED. Rohit Ashok Tiwari is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (1)
2y 3m 1y 2m Interval
Company Name | Designation | Date of Appointment |
---|---|---|
KREGAR PHARMA PRIVATE LIMITED | Managing Director | 30-Sep-2016 |
BASK-RAY INDIA PRIVATE LIMITED | Director | 19-Apr-2024 |